SLXN
Income statement / Annual
Last year (2024), Silexion Therapeutics LTD's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Silexion Therapeutics LTD's net income was $16.51 M.
See Silexion Therapeutics LTD,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$5.82 M
|
$3.71 M
|
$3.23 M
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$6.76 M
|
$928,000.00
|
$577,000.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$6.76 M
|
$928,000.00
|
$577,000.00
|
$943,933.00
|
$195,860.00
|
| Other Expenses |
$0.00
|
$45,000.00
|
$57,000.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$12.57 M
|
$4.68 M
|
$3.86 M
|
$943,933.00
|
$195,860.00
|
| Cost And Expenses |
$0.00
|
$4.68 M
|
$3.86 M
|
-$943,933.00
|
-$195,860.00
|
| Interest Income |
$0.00
|
$153,000.00
|
$114,000.00
|
$6,372.00
|
$0.00
|
| Interest Expense |
$0.00
|
$9,000.00
|
$85,000.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
$45,000.00
|
$57,000.00
|
$0.00
|
$0.00
|
| EBITDA |
-$16.43 M |
-$4.64 M |
-$3.80 M |
-$755,218.00 |
-$195,860.00 |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$0.00
|
-$395,000.00
|
$396,000.00
|
$188,715.00
|
$0.00
|
| Income Before Tax |
$16.51 M
|
-$5.08 M
|
-$3.46 M
|
-$755,218.00
|
-$195,860.00
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$32,000.00
|
$24,000.00
|
$0.00
|
$0.00
|
| Net Income |
$16.51 M
|
-$4.94 M
|
-$3.22 M
|
-$755,218.00
|
-$195,860.00
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
| EPS |
2.03 |
-0.61 |
-0.39 |
-0.46 |
-0.12 |
| EPS Diluted |
2.03 |
-0.61 |
-0.39 |
-0.46 |
-0.12 |
| Weighted Average Shares Out |
$623,846.00
|
$8.15 M
|
$8.15 M
|
$1.65 M
|
$1.65 M
|
| Weighted Average Shares Out Diluted |
$623,846.00
|
$8.15 M
|
$8.15 M
|
$1.65 M
|
$1.65 M
|
| Link |
|
|
|
|
|
